Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 2, 2003, Pages 233-239

  Du, Wen Min ^a   Miao, Chao Yu ^a   Liu, Jian Guo ^a   Shen, Fu Ming ^a   Yang, Xiang Qun ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arterial baroreflex; Blood pressure; Blood pressure variability; End organ damage; Hydralazine; Hypertension; Ketanserin; Spontaneously hypertensive rat

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDRALAZINE; KETANSERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GLOMERULONEPHRITIS; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; KIDNEY INJURY; LONG TERM CARE; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR LESION;

ANIMALS; BLOOD PRESSURE; FEMALE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KETANSERIN; KIDNEY FAILURE, CHRONIC; MALE; RATS; RATS, INBRED SHR;

EID: 0037309366     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200302000-00012     Document Type: Article

References (23)

1. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol. 2001;28:709-15.
2. Miao CY, Shen FM, Su DF. Blood pressure variability is increased in genetic hypertension and L-NAME-induced hypertension. Acta Pharmacol Sin. 2001;22:137-40.
3. Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:93-8.
4. Mancia G, Frattola A, Parati G, et al. Blood pressure variability and organ damage. J Cardiovasc Pharmacol. 1994;24(suppl A):S6-11.
5. Shan ZZ, Dai, SM, Su DF. Relationship between baroreceptor reflex function and end-organ damage in spontaneously hypertensive rats. Am J Physiol. 1999;277:H1200-6.
6. 2 serotonergic receptors. J Pharmacol Exp Ther. 1981;218:217-30.
7. Reimann IW, Frohlich JC. Mechanisms of antihypertensive action of ketanserin in man. BMJ. 1983;287:381-3.
8. Miao CY, Xie HH, Yu H, et al. Ketanserin stabilizes blood pressure in conscious spontaneously hypertensive rats. Eur J Pharmacol. 2003; (in press).
9. Su DF, Cerutti C, Barres C, et al. Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain. Am J Physiol. 1986;251:H1111-7.
10. Su DF, Chen L, Kong XB, et al. Determination of arterial baroreflex-blood pressure control in conscious rats. Acta Pharmacol Sin. 2002;23:103-9.
11. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res. 1969;24:109-21.
12. Su DF, Cerutti C, Barres C, et al. Arterial baroreflex control of heart period is not related to blood pressure variability in conscious hypertensive and normotensive rats. Clin Exp Pharmacol Physiol. 1992;19:767-75.
13. Notoya M, Nakamura M, Mizojiri K. Effects of lisinopril on the structure of renal arterioles. Hypertension. 1996;27:364-70.
14. Higashi T, Kobayashi N, Hara K, et al. Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats. J Cardiovasc Pharmacol. 2000;35:564-71.
15. Miao CY, Tao X, Gong K, et al. Arterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol. 2001;37:6-15.
16. Mancia G, Ferrari A, Gregorini L, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human being. Circ Res. 1983;53:96-104.
17. 2A-receptor. J Cardiovasc Pharmacol. 2000;36:681-6.
18. Jacob HJ, Alper RH, Brody J. Lability of arterial pressure after baroreceptor denervation is not pressure dependent. Hypertension. 1989;14:501-10.
19. Su DF, Miao CY. Arterial baroreflex function in conscious rats. Acta Pharmacol Sin. 2002;23:673-9.
20. Shan ZZ, Dai SM, Su DF. Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats. J Cardiovasc Pharmacol. 2001;38:427-37.
21. La Rovere MT, Specchia G, Mortara A, et al. Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with a first myocardial infarction: a prospective study. Circulation. 1988;78:816-24.
22. La Rovere MT, Bigger JT, Marcus FI, et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478-84.
23. La Rovere MT, Pinna GD, Hohnloser SH, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias. Circulation. 2001;103:2072-7.